SU950188A3 - Process for producing derivatives of 4(5)-mercaptomethylimidazoles - Google Patents
Process for producing derivatives of 4(5)-mercaptomethylimidazoles Download PDFInfo
- Publication number
- SU950188A3 SU950188A3 SU792802997A SU2802997A SU950188A3 SU 950188 A3 SU950188 A3 SU 950188A3 SU 792802997 A SU792802997 A SU 792802997A SU 2802997 A SU2802997 A SU 2802997A SU 950188 A3 SU950188 A3 SU 950188A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- carried out
- fact
- formula
- methyl
- methanol
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 23
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 5
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims description 3
- 239000002841 Lewis acid Substances 0.000 claims description 2
- 239000000010 aprotic solvent Substances 0.000 claims description 2
- 239000012298 atmosphere Substances 0.000 claims description 2
- 239000012458 free base Substances 0.000 claims description 2
- 150000007517 lewis acids Chemical class 0.000 claims description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims 1
- 229910052783 alkali metal Inorganic materials 0.000 claims 1
- 150000001340 alkali metals Chemical class 0.000 claims 1
- 229910052796 boron Inorganic materials 0.000 claims 1
- 238000004821 distillation Methods 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 239000002798 polar solvent Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 7
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 208000000718 duodenal ulcer Diseases 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- OGMADIBCHLQMIP-UHFFFAOYSA-N 2-aminoethanethiol;hydron;chloride Chemical compound Cl.NCCS OGMADIBCHLQMIP-UHFFFAOYSA-N 0.000 description 1
- KEWLVUBYGUZFKX-UHFFFAOYSA-N 2-ethylguanidine Chemical compound CCNC(N)=N KEWLVUBYGUZFKX-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 101100001674 Emericella variicolor andI gene Proteins 0.000 description 1
- GHVZOJONCUEWAV-UHFFFAOYSA-N [K].CCO Chemical compound [K].CCO GHVZOJONCUEWAV-UHFFFAOYSA-N 0.000 description 1
- FPWNQPQTICPCOM-UHFFFAOYSA-N acetonitrile;propan-2-ol Chemical compound CC#N.CC(C)O FPWNQPQTICPCOM-UHFFFAOYSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229940097265 cysteamine hydrochloride Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Изобретение относитс к новому .способу получени производных 4(5)-меркаптометилимидазолов общей формуThis invention relates to a novel process for the preparation of 4 (5) -mercaptomethyl or imidazole derivatives.
-S-рСНз-к а у -S-рСНз-к а у
IIftfm-л .-v -к.- .rnvvW 1 . IIftfm-l. -V -k.- .rnvvW 1.
CHj $СН2 CH2T HC«HR J i -jTdHjSCiigCHjUHCNira ,, . 1.-вД-СНз где R - алкильный остаток с 1-3 атомами углерода в цепи, которые вл ютс ценными биологически активными соединени ми и используютс дл лечени зв желудка и двенадцатиперстной кишки. Известны способы получени соединений Общей формулы I или I а трем методами согласно схеме ijf 2J, з и UJ. Цель изобретени - увеличение выхода целевого продукта и упрощение процесса. Поставленна цель достигаетс спо собом получени соединений общейCHj $ CH2 CH2T HC "HR J i -jTdHjSCiigCHjUHCNira ,,. 1.-vD-CH3 where R is an alkyl residue with 1 to 3 carbon atoms in the chain, which are valuable biologically active compounds and are used to treat stomach and duodenal ulcers. Methods are known for preparing compounds of General Formula I or I and by three methods according to the scheme ijf 2J, 3 and UJ. The purpose of the invention is to increase the yield of the target product and simplify the process. The goal is achieved by the method of obtaining compounds of total
формулы I или 1а, заключающимс в том, что соединение формулыFormula I or 1a, comprising the compound of formula
f -СНз Т-СП2&11f -СНз Т-СП2 & 11
1| II или I I 1 | II or I I
-Шз-Shz
иIandI
н.n
Ш) W)
Па или его соль подвергают взаимодействию с соединением формулы -Сз:ьг pir-C-irH-R.( где R имеет вышеуказанные значени , с выделением целевого продукта. Взаимодействие осуществл ют предпочтительно в метаноле, этаноле или диметилсульфоксиде при -5 - 80 С. Если примен ют свободное основание соединени II, то процесс провод т предпочтительно в апротонном растворителе с добав.аением кислоты Льюиса, такой, как бортрифторидэтилэфират, при 0-20с. Образование анионов соединени II лучше всего происходит под воздействием раствора алкогол та щелочного металла. Наилучшие результаты получают при использовании метилата натри при -5 - 20 С в инертной атмосфере. Выход по предлагаемому способу врасчете на 4(5)-тиометил-5(4)-метилимидазол практически количественный, причем вместо дорогого цистеамингидрохлорида примен ют очень дешевый этаноламин или этиленимин. Таким образом, в предлагаемом способе примен ют дешевые и легко до ступные реагенты и получают целевой продукт с более высокими выходами. Соединени формулы Iпримен ютс в медицине в качестве средства дл блокировани рецепторов Н,, т.е. дл лечени зв желудка и двенадцатиперс тной кишки.В примерах указаны услови и мето осуществлени способа дл иллюстраци изобретени , но без какого-либо их ограничени . Приготовление 4(5)-метил-5(4)-мер каптометилимидазолгидрохлорида. Приготовл ют 4,5%-ный раствор KHS в абсолютном этаноле посредством про пускани сухого сероводорода через (спиртовой раствор этилата кали . Это раствор прибавл ют по капл м к раствору 4(5)-метил-5(4)-хлорметилимидазолгидрохлорида (15 г, 0,09 моль) в абсолютном этаноле (140 мл) при , 0-5°С при перемешивании. Затем перемешивают еще 2 ч, после чего прибавл ют раствор хлористого водорода в изопропаноле до достижени значени рН приблизительно 1. Выделившиес неорганические-соли отфильтровывают , фильтрат выпаривают досуха, и остаток раствор ют в этаноле (300 мл) с нагреванием. После прибавлени активированного угл отфильтровывают , оп ть выпаривают досуха, причем кристаллизуетс сырой продукт. Т.пл. 283-285°С (14,5 г). После перекристаллизации из изопропанола (60 мл) получают 11,2 г чистого продукта. Т.пл.290291 С , ИР (КВг): 2800 до 3200 (широкий ), 1640, 1530, 1480, 1440, 1095, 815 см-Ч „ , пример 1. N -циано-N -метил-N- 2- (5-мeтилимидaзoлил-4-мeтилмеркапто )-этилJ-гуанидин. К 4(5)-мeтил-4-(5)-мepкaптoмeтилимидaзoлгидlC )OXЛOpилy (1,64 г, 10 ммол в метаноле прибавл ют раствор из N -циано-N-мeтил-N-этилeнryaнидинa (1,48 г, 12 ммоль) в метаноле (50мл при при перемешивании. После шес тичасового перемешивани прибавл ют 10 МП метанольного раствора аммиака раствор упаривают и кристаллизуют ос таток из изопропанола. Выход 75-80% Т.пл.141-143с. ,, .Пример 2. Н -циано-N-метил -N-{.2- (5-метилимидазолил-4-метилмер капто)-этил -гуанидин. . Способ провод т аналогично примеру 1, но в качестве растворител примен ют диметилсульфоксид вместо метанола . Взаимодействие провод т в течение 2 ч при , после этого растворитель в вакууме выпаривают досуха. Остаток перекристаллизовывают из изопропанолацетонитрила . Выход продукта 70-75%. Т.пл. 141-143с. П р и м е р 3. N -uиaнo-N -этил-N- 2- (5-метилимидазолил-4-метилмеркапто )-этилJ-гуанидин. Раствор ют 4 (5)-Метил-5 (4)-меркаптометилимиданола (6,5 г; 0,05 моль) в тетрагидрофуране (80 мл) и прибавл ют раствор из н-циано-М-этил-М -этиленгуанидина- ( 8, 28 г, 0,06 моль) в тетрагидрофуране (40 мл). Затем прибавл ют по капл м раствор диэтилового эфира бортрифторида (0,05 моль) при 10-15 С и реакционную смесь перемешивают 4 ч. Обработку осуществл ют согласно примеру 1. Выход 80-85%. Т.пл.117-119 С, Пример 4. N -циано-N -метил-N- 2- (5 Метилимидазолил-4-метилмеркаптоэтил -гуанидин . Раствор ют 13,8 г (84 ммоль) 4(5)-тиометил-5- (4)-метилимидазолгидрохлорида в 200 мл абсолютного метанола и прибавл ют по капл м в атмосфере азота при в течение 15 мин 3,17мл 28,5%-ного раствора метилата натри в метаноле. Затем еще прибавл ют по капл м , все еще при охлаждении, 9,93 г (80 ммоль.) и -циано-N -метил-Ы-этиленгуанидина , растворенного в 100 мл абсолютного метанола. Реакцию осуществл ют при перемешивании в течение 1012 ч при комнатной температуре, и с помощью тонкослойной хроматографией след т за ходом взаимодействи (смесь элюентов: ацетонитрил уксусный-эфир-метанол-концентрированный аммиак 10:5:2:1). В конце реакции на хроматограмме практически видны только п тна продукта, в то врем как больше Не по вл ютс п тна исходных соединений . После этого фильтруют выпавший неорганический осадок, выпаривают фильтрат досуха, а остаток раствор ют в гор чем пропаноле. Фильтруют вторую порцию неорганической соли и кр 1сталлизуют продукт охлаждением до О С. Получают 70-80% чистого N-циано -N -метил-N- 2-(5-метилимидазолил-4-метилмеркаптоэтил )-гуанидина с Т.пл. 141-143 С, и последующим концентрированием и кристаллизацией маточного раствора получают этот продукт с общим выходом 90-96%. Пример 5. N -циaнo-N -метил-N- 2-(5-метилимидазолил-4)-метилмеркаптоэтил -гуанидин . Процесс осуществл ют аналогично примеру 4, но в качестве растворител вместо метанола примен ют ацетонитрил , который может быть также смеPa or its salt is reacted with a compound of the formula C 3: pir-C-irH-R (where R is as defined above, to isolate the desired product. The reaction is carried out preferably in methanol, ethanol or dimethyl sulfoxide at -5 - 80 ° C. If the free base of compound II is used, the process is preferably carried out in an aprotic solvent with the addition of a Lewis acid, such as boron trifluoride ethyl ether, at 0-20 sec. The formation of anions of compound II is best effected by the action of an alkali methane alcohol solution. The best results are obtained when using sodium methoxide at -5-20 ° C in an inert atmosphere. The yield of the proposed method calculated for 4 (5) -thiomethyl-5 (4) -methylimidazole is almost quantitative, and very cheap ethanolamine is used instead of expensive cysteamine hydrochloride or ethyleneimine. Thus, in the proposed method, cheap and readily available reagents are used and the desired product is obtained in higher yields. The compounds of the formula I are used in medicine as a means for blocking the H receptors, i.e. for the treatment of gastric and duodenal ulcers. In the examples, the conditions and methods of carrying out the method are shown to illustrate the invention, but without any limitation thereof. Preparation of 4 (5) -methyl-5 (4) -mer captomethylimidazole hydrochloride. A 4.5% solution of KHS in absolute ethanol is prepared by passing dry hydrogen sulfide through (an alcoholic solution of potassium ethylate. This solution is added dropwise to a solution of 4 (5) -methyl-5 (4) -chloromethylimidazol hydrochloride (15 g , 0.09 mol) in absolute ethanol (140 ml) at 0-5 ° C with stirring. Then it is stirred for another 2 h, then a solution of hydrogen chloride in isopropanol is added until the pH reaches approximately 1. The isolated inorganic salts are filtered , the filtrate is evaporated to dryness, and the residue is dissolved in ethanol (30 0 ml) with heating. After the addition of activated carbon, it is filtered, evaporated again to dryness, and the crude product is crystallized, mp 283-285 ° C (14.5 g). After recrystallization from isopropanol (60 ml), 11.2 are obtained. g of pure product. So pl.290291 C, IR (KVg): 2800 to 3200 (wide), 1640, 1530, 1480, 1440, 1095, 815 cm-H, example 1. N-cyano-N-methyl- N-2- (5-methylimidazolyl-4-methylmercapto) -ethylJ-guanidine K 4 (5) -methyl-4- (5) -mercaptomethylimidazole hydrochloride (C) OXLopropyl (1.64 g, 10 mmol in methanol;); -cyano-N-methyl-N-ethylenediamine (1.48 g, 12 mmol) in methanol (50 ml with stirring nii. After six hours of stirring, 10 MP of methanolic ammonia solution is added and the solution is evaporated and the residue is crystallized from isopropanol. The yield of 75-80% So pl.141-143s. ,, Example 2. H-cyano-N-methyl-N - {. 2- (5-methylimidazolyl-4-methylmer capto) -ethyl-guanidine. . The method is carried out analogously to example 1, but dimethyl sulfoxide instead of methanol is used as a solvent. The reaction is carried out for 2 hours at which time the solvent is evaporated to dryness in vacuo. The residue is recrystallized from isopropanol acetonitrile. The product yield 70-75%. M.p. 141-143c. PRI me R 3. N-iano-N-ethyl-N-2- (5-methylimidazolyl-4-methylmercapto) ethyl-guanidine. 4 (5) -Methyl-5 (4) -mercaptomethylimidanol (6.5 g; 0.05 mol) was dissolved in tetrahydrofuran (80 ml) and a solution of n-cyano-M-ethyl-M-ethyleneguanidine- ( 8, 28 g, 0.06 mol) in tetrahydrofuran (40 ml). A solution of diethyl ether of boron trifluoride (0.05 mol) is then added dropwise at 10-15 ° C and the reaction mixture is stirred for 4 hours. The treatment is carried out according to Example 1. Yield 80-85%. Mp.117-119 C, Example 4. N-cyano-N-methyl-N- 2- (5 Methylimidazolyl-4-methyl mercaptoethyl-guanidine. 13.8 g (84 mmol) 4 (5) -thiomethyl) are dissolved -5- (4) -methyl-imidazole hydrochloride in 200 ml of absolute methanol and 3.17 ml of a 28.5% solution of sodium methylate in methanol are added dropwise in a nitrogen atmosphere at 15 minutes, then added dropwise. still with cooling, 9.93 g (80 mmol.) and -cyano-N -methyl-L-ethyleneguanidine dissolved in 100 ml of absolute methanol. The reaction is carried out with stirring for 1012 hours at room temperature and using a thin The reaction was monitored by oi chromatography (mixture of eluents: acetonitrile / ethyl acetate / methanol / concentrated ammonia 10: 5: 2: 1). spots of starting compounds. After that, the precipitated inorganic precipitate is filtered, the filtrate is evaporated to dryness, and the residue is dissolved in hot propanol. -methyl-N- 2- (5-methylimide zolyl-4-methylmercaptoethyl) -guanidine with m.p. 141-143 ° C, and subsequent concentration and crystallization of the mother liquor, this product is obtained in a total yield of 90-96%. Example 5. N-cyano-N-methyl-N-2- (5-methylimidazolyl-4) -methyl mercaptoethyl-guanidine. The process is carried out analogously to example 4, but acetonitrile is used as a solvent instead of methanol, which can also be mixed.
Claims (1)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1634077A CH631971A5 (en) | 1977-12-30 | 1977-12-30 | Process for preparing imidazole derivatives |
| CH1069578 | 1978-10-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU950188A3 true SU950188A3 (en) | 1982-08-07 |
Family
ID=25707086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU792802997A SU950188A3 (en) | 1977-12-30 | 1979-08-21 | Process for producing derivatives of 4(5)-mercaptomethylimidazoles |
Country Status (16)
| Country | Link |
|---|---|
| JP (1) | JPS55500026A (en) |
| CS (1) | CS207750B2 (en) |
| DE (1) | DE2857324D2 (en) |
| DK (1) | DK319679A (en) |
| FI (1) | FI784018A7 (en) |
| FR (1) | FR2413373A1 (en) |
| GB (1) | GB2036003B (en) |
| GR (1) | GR65283B (en) |
| IT (1) | IT1102765B (en) |
| NL (1) | NL171054C (en) |
| NO (1) | NO784350L (en) |
| PL (1) | PL113033B1 (en) |
| SE (1) | SE7907148L (en) |
| SU (1) | SU950188A3 (en) |
| WO (1) | WO1979000466A1 (en) |
| YU (1) | YU313178A (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS213376B2 (en) * | 1978-05-12 | 1982-04-09 | Crc Ricerca Chim | Method of making the derivatives of n-kyanoazomethines |
| LU81178A1 (en) * | 1978-05-12 | 1979-09-10 | Crc Ricerca Chim | NEW THIOLD DERIVATIVES OF IMIDAZOLE |
| WO1981000255A1 (en) * | 1979-07-16 | 1981-02-05 | Rech Syntheses Organ | Imino-alkyl and amino-nitril cyano-guanidines |
| JPS56501008A (en) * | 1979-07-30 | 1981-07-23 | ||
| CA1181084A (en) * | 1980-01-08 | 1985-01-15 | Glaxo Group Limited | Process for the preparation of a furan derivative |
| PT72320B (en) * | 1980-01-08 | 1982-07-23 | Glaxo Group Ltd | Process for preparation of a furan derivative |
| EP0058286A1 (en) * | 1981-02-12 | 1982-08-25 | Société de Recherches et de Synthèses Organiques SA | Geometrical isomers of cyano-guanidines, and processes for their preparation |
| GB8502446D0 (en) * | 1985-01-31 | 1985-03-06 | Smith Kline French Lab | Preparing aziridine derivative |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1533380A (en) * | 1974-09-02 | 1978-11-22 | Smith Kline French Lab | Process for the preparation of heterocyclic substituted thioureas and h-cyanoguanidines |
| GB1531231A (en) * | 1974-09-02 | 1978-11-08 | Smith Kline French Lab | Process for the production of cyanoguanidine derivatives |
| IL56265A (en) * | 1977-12-28 | 1982-08-31 | Om Lab Sa | Process for preparing imidazolyl methylthio guanidine derivatives and a novel intermediate therefor |
-
1978
- 1978-12-22 GR GR57973A patent/GR65283B/en unknown
- 1978-12-22 NO NO784350A patent/NO784350L/en unknown
- 1978-12-28 FI FI784018A patent/FI784018A7/en unknown
- 1978-12-28 GB GB7928551A patent/GB2036003B/en not_active Expired
- 1978-12-28 WO PCT/CH1978/000058 patent/WO1979000466A1/en not_active Ceased
- 1978-12-28 IT IT31352/78A patent/IT1102765B/en active
- 1978-12-28 DE DE78CH7800058T patent/DE2857324D2/en not_active Expired
- 1978-12-28 JP JP50020578A patent/JPS55500026A/ja active Pending
- 1978-12-29 NL NLAANVRAGE7812662,A patent/NL171054C/en not_active IP Right Cessation
- 1978-12-29 CS CS789198A patent/CS207750B2/en unknown
- 1978-12-29 FR FR7836922A patent/FR2413373A1/en active Pending
- 1978-12-29 YU YU03131/78A patent/YU313178A/en unknown
- 1978-12-30 PL PL1978212389A patent/PL113033B1/en unknown
-
1979
- 1979-07-30 DK DK319679A patent/DK319679A/en not_active Application Discontinuation
- 1979-08-21 SU SU792802997A patent/SU950188A3/en active
- 1979-08-28 SE SE7907148A patent/SE7907148L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL113033B1 (en) | 1980-11-29 |
| WO1979000466A1 (en) | 1979-07-26 |
| NL171054B (en) | 1982-09-01 |
| YU313178A (en) | 1982-10-31 |
| GR65283B (en) | 1980-08-01 |
| GB2036003A (en) | 1980-06-25 |
| JPS55500026A (en) | 1980-01-24 |
| IT7831352A0 (en) | 1978-12-28 |
| IT1102765B (en) | 1985-10-07 |
| SE7907148L (en) | 1979-08-28 |
| CS207750B2 (en) | 1981-08-31 |
| NL171054C (en) | 1983-02-01 |
| NO784350L (en) | 1979-07-03 |
| NL7812662A (en) | 1979-07-03 |
| FI784018A7 (en) | 1979-07-01 |
| DE2857324D2 (en) | 1980-11-20 |
| FR2413373A1 (en) | 1979-07-27 |
| DK319679A (en) | 1979-08-30 |
| GB2036003B (en) | 1982-08-18 |
| PL212389A1 (en) | 1979-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4794185A (en) | Process for the preparation of imidazopyridines | |
| SU888821A3 (en) | Method of preparing 5-(substituted phehyl)-oxazolidinones or their sulphur-containing analogs | |
| SU888815A3 (en) | Method of preparing nitrocompound | |
| SU950188A3 (en) | Process for producing derivatives of 4(5)-mercaptomethylimidazoles | |
| RU1802811C (en) | Method for preparing n-(substituted alkyl)-n-(imidazole-4-yl)-gyanidine or its acid additive salts | |
| IE48532B1 (en) | Process for preparing h2-receptor antagonist cimetidine | |
| KR910005850B1 (en) | Process for the preparation of imidazo (1,5-a) pyrimidien derivatives | |
| KR840002007B1 (en) | Method for producing furan derivative | |
| US4394516A (en) | Process for the preparation of a furan derivative | |
| SU936811A3 (en) | Process for producing pyridazinylhydrazones or their acid additive salts | |
| SU1227111A3 (en) | Method of producing guanidine derivatives or their tautomeric compounds or their salts | |
| US3320272A (en) | Process for preparing z-alkoxycyclo- heptimidazole derivatives | |
| US3461131A (en) | Process for preparing 2-substituted cycloheptimidazole derivatives | |
| Shimadzu et al. | Studies on furan derivatives. XIV. Nucleophilic substitution of methyl 5‐nitro‐2‐furancarboxylate and 5‐Nitrofuran‐2‐nitrile | |
| SU900802A3 (en) | Process for preparing ethyleleiminocyanoazomethines | |
| KR102441327B1 (en) | Novel method for preparing diaminopyrimidine derivatives or acid addition salts thereof | |
| US4200761A (en) | Process for preparing N-cyano-N'methyl-N"-{2-[(4-methyl-5-imidazolyl)-methylthio]-ethyl} guanidine | |
| US3226379A (en) | Novel 1,3-bis(polyhydroxyalkyl)-2-imidazolidinones and 1,3-bis(polyhydroxyalkyl)-imidazolidine-2-thiones | |
| EP1927590B1 (en) | Method for producing 1-substituted-5-acylimidazole compound | |
| KR920004137B1 (en) | Method for preparing imidazole derivative | |
| EP0034421B1 (en) | N-phenyl-n'-cyano-0-phenylisoureas and process for their preparation | |
| SU655307A3 (en) | Method of obtaining guanidine derivatives or salts thereof | |
| NO863769L (en) | PROCEDURE FOR THE PREPARATION OF 4-HYDROXY-2-OXOPYRROLIN-1-YL-ACETAMIDE. | |
| SU437294A1 (en) | The method of obtaining derivatives of 2-amino-dihydro-benzodiazepinone | |
| EP0276574B1 (en) | Alpha-acyloxyketone derivatives |